Efficacy and Safety Profile of Lenvatinib and Sorafenib in The Treatment of Adult Patients with Advanced Radioactive-Iodine-Refractory Differentiated Thyroid Cancer (RR-DTC)
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.2075
https://www.valueinhealthjournal.com/article/S1098-3015(16)33441-6/fulltext
Title :
Efficacy and Safety Profile of Lenvatinib and Sorafenib in The Treatment of Adult Patients with Advanced Radioactive-Iodine-Refractory Differentiated Thyroid Cancer (RR-DTC)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33441-6&doi=10.1016/j.jval.2016.09.2075
First page :
A708
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1966